Diahome: Reshaping The Telemedicines Industry With Patient-Centric Solutions

 Prof. A. Ramachandran, Co-Founder, Dr. Nanditha Arun, Co-Founder, Dr. Arun Raghav, Co-Founder

Prof. A. Ramachandran, Co-Founder, Dr. Nanditha Arun, Co-Founder

Dr. Arun Raghav, Co-Founder

The global telemedicine industry is booming, and India is presenting an immense scope of growth fueled by factors like growing penetration of smartphones, greater healthcare awareness, the demand for remote healthcare access, and more. The growth of the industry is further propelled by supportive governmental policies as well as growing digital infrastructure. The convenience offered by telemedicine is leading to its quick adoption and offering tremendous opportunities for advancement, nationwide.

The challenges related to limited accessibility to specialized care, complexities of managing chronic diseases, as well as inconvenience of regularly visiting hospitals further act as a factor driving patients towards telemedicine. Within this realm, ARH Digital Services Ltd., (Diahome) stands out as a reliable service provider, offering comprehensive solutions such as virtual consultations with leading healthcare experts, homebased diagnostics, continuous monitoring, and personalized treatment plans. Amalgamating technology and a drive to make healthcare accessible to all, it is empowering patients to overcome barriers to healthcare access by bringing it brings convenience, simplicity, comfort, affordability, and improved health outcomes in one place. 

Digital & Home-Based Solutions

Diahome, evolved from the ARH Hospitals, founded by Prof. Dr. A. Ramachandran, Dr. Arun Raghavan & Dr. Nanditha Arun with the aim of providing specialized services to patients suffering from diabetes. Today, it offers a unique combination of digital care and home-based services targeted towards these patients, to make it simpler to navigate through the complex ailment. Going beyond mere virtual consultations, the company offers 360-degree care for diabetes patients, right at their doorstep. Diahome’s user-friendly platform innovatively combines telemedicine technology along with lab tests at home facility, physical examinations, interactive video consultations, and medicine delivery to create a hassle-free and tailored experience for users struggling with diabetes. Through these comprehensive consultations along with pharmacy, lab, diet, and dedicated care management solutions, the firm is not just revolutionizing the industry, but setting new benchmarks for promoting patient-centric healthcare solutions.                                                         

Nanditha

“Our individualized and comprehensive diabetes care empowers patients to effectively manage their condition by providing personalized treatment plans, continuous monitoring, and ongoing support. Through telemedicine consultations, home-based diagnostics, and access to a multidisciplinary team of healthcare professionals, we ensure that patients receive tailored care that addresses their unique needs and challenges. By promoting regular monitoring, medication adherence, lifestyle modifications, and education, we empower patients to maintain optimal blood sugar levels and prevent complications, ultimately helping them lead healthier lives with diabetes”, shares Prof Ramachandran, Chairman, MD & Chief Consultant Diabetologist, Diahome.

What sets Diahome apart is its ability to offer end-to-end services, making telemedicine for diabetes more than a virtual consultation practice. It is composed of a team of diversely qualified medical professionals including specialists such as diabetologists, dentists, nutritionists, cardiologists, and other professionals with expertise ranging across technology, data science, and healthcare management. With this highly qualified team of seasoned professionals, the firm excels in providing personalized diabetes care.

Diahome’s technology experts fuel the firm’s passion for innovation, developing cutting-edge telemedicine platforms

Prof. A. Ramachandran, Co-Founder, Dr. Nanditha Arun, Co-Founder, Dr. Arun Raghav, Co-Founder


Diahome’s technology experts fuel the firm’s passion for innovation, developing cutting-edge telemedicine platforms. Simultaneously, its data scientists analyze comprehensive patient data contained in electronic health records supported by the platform to accurately optimize treatment outcomes. On the other hand, their healthcare management professionals oversee routine operations, making sure efficiency and quality reign supreme. With the expertise of every individual, the firm moves one step ahead in its goals of expansion and serving clients with the best quality of services. 

 Dr. Arun, Director, Consultant Diabetologist & Intensivist, Diahome elaborates, “Leveraging advanced technologies, we ensure seamless communication between the patients as well as their healthcare providers, irrespective of where each of them is geographically located. This capability helps patients overcome distance barriers, and access quality healthcare from the comfort for their homes. This plays a pivotal role in time-sensitive issues, allowing our patients to seek care and guidance in time, thereby improving their recovery and disease management capabilities. With such unique and indispensable features, technology is an integral part of our solutions”.                                  

Arun Raghavan

Future Roadmap

Built on the legacy of ARH Hospital, founded especially for the care of diabetic patients, and leveraging its partnership with the India Diabetes Research Foundation (IDRF), Diahome has come a long way in transforming the telemedicine landscape, particularly with regards to diabetes patients. Since its inception, the company has been trusted by thousands of individuals who are now enjoying easy diabetes management practices every day.

“Our partnership with IDRF significantly enhances our clinical output by providing cutting-edge research, evidence-based guidelines, and expert insights. Its extensive research on diabetes management informs our treatment protocols, ensuring they are scientifically sound and effective. Collaboration with IDRF allows us to incorporate the latest advancements and innovations in diabetes care into our platform.                                         

Additionally, the data-driven approach helps us continuously refine and optimize our services, resulting in improved patient outcomes. This partnership ensures that we remain at the forefront of diabetes care, delivering the highest standard of clinical excellence to our patients”, shares Dr. Nanditha, Director & Consultant Diabetologist, Diahome.

As the company continues to grow and refine through its interconnectedness with IDRF, ARH Hospital, and Diahome ecosystem, its future strategies remain centered on innovation, expansion, and enhancing patient care. With the aim to expand technology integration, the firm aims to leverage AI and IoT for more personalized treatment plans and remote monitoring. It is also planning to expand its services portfolio to encompass specialized care programs and wellness initiatives. 

Dedicated to enhancing patient outcomes, expanding access to quality healthcare, and leading the way in telemedicine innovation, Diahome is taking proactive steps to stay ahead of the game. Through its relentless pursuit of excellence, it aims to transform the healthcare delivery standards, and empower patients to live healthier lives. With a strong focus on integrity, transparency, and compassion, it will continue to strive to be a trusted partner in the patients' health journeys.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.